Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Screening of congenital heart disease patients using multiplex ligation-dependent probe amplification: early diagnosis of syndromic patients

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. First reported adult patient with TARP syndrome: A case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Ocular albinism with infertility and late-onset sensorineural hearing loss

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Stakeholders in psychiatry and their attitudes toward receiving pertinent and incident findings in genomic research

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Genome-wide association study implicates CHRNA2 in cannabis use disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Can Animal Models of Copy Number Variants That Predispose to Schizophrenia Elucidate Underlying Biology?

    Research output: Contribution to journalReviewResearchpeer-review

  • Karina Meden Sørensen
  • Milad El-Segaier
  • Eva Fernlund
  • Ab Errami
  • Patrice Bouvagnet
  • Nancy Nehme
  • Jesper Steensberg
  • Vibeke E. Hjortdal
  • Maria Soller
  • Mohaddeseh Behjati
  • Thomas Werge
  • Eva Maria Kirchoff
  • Jan Schouten
  • Niels Tommerup
  • Paal Skytt Andersen
  • Lars Allan Larsen
View graph of relations
Recurrent copy number variants (CNVs) are found in a significant proportion of patients with congenital heart disease (CHD) and some of these CNVs are associated with other developmental defects. In some syndromic patients, CHD may be the first presenting symptom, thus screening of patients with CHD for CNVs in specific genomic regions may lead to early diagnosis and awareness of extracardiac symptoms. We designed a multiplex ligation-dependent probe amplification (MLPA) assay specifically for screening of CHD patients. The MLPA assay allows for simultaneous analysis of CNVs in 25 genomic regions previously associated with CHD. We screened blood samples from 402 CHD patients and identified 14 rare CNVs in 13 (3.2%) patients. Five CNVs were de novo and six where inherited from a healthy parent. The MLPA screen led to early syndrome diagnosis in two of these patients. We conclude that the MLPA assay detects clinically relevant CNVs and suggest that it could be used within pediatric cardiology as a first tier screen to detect clinically relevant CNVs and identify syndromic patients at an early stage.
Original languageEnglish
JournalAmerican Journal of Medical Genetics. Part A
Volume158A
Issue number4
Pages (from-to)720-5
Number of pages6
ISSN1552-4825
DOIs
Publication statusPublished - 2012

    Research areas

  • Adolescent, Aged, Child, Child, Preschool, Chromosome Aberrations, DNA Copy Number Variations, Female, Gene Dosage, Heart Defects, Congenital, Heart Diseases, Humans, Infant, Infant, Newborn, Male, Multiplex Polymerase Chain Reaction, Nucleic Acid Amplification Techniques

ID: 36514810